Global Bioresorbable Medical Material Revenue is nearly 973 M USD In 2016
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, Global market of Bioresorbable Medical Material developed rapidly, with an average growth rate of 9.24%. In 2016, Global Revenue of Bioresorbable Medical Material is nearly 973 M USD; the actual sales are about 311 MT.
The global average price of Bioresorbable Medical Material experienced a fluctuation trend, from 3100 USD/Kg in 2012 to 3128 USD/Kg in 2016. With the situation of global economy, prices will present a fluctuation trend in the following five years.
The classification of PLA, PGA, PCL, PLGA, Polysaccharides and others, and the proportion of PLA in 2016 is about 27%. And the proportion of PCL, PGA is about 19% and 16%, respectively.
Bioresorbable Medical Material is widely used for Orthopedics, Drug Delivery and others. The most proportion of Bioresorbable Medical Material is Orthopedics, and the proportion of Orthopedics in 2016 is 44%.
USA is the largest consumption place, with a consumption market share nearly 41% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 32%.
Market competition is not intense. Evonik, Corbion, DSM, Mitsui?Chemicals, PCAS, Poly-Med, KLS Martin, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.